Cronos Group Inc. - Common Share (CRON): Price and Financial Metrics


Cronos Group Inc. - Common Share (CRON): $3.46

0.20 (+6.13%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CRON to Watchlist
Sign Up

Industry: Agriculture


Ranked

of

in industry

CRON POWR Grades

  • Growth is the dimension where CRON ranks best; there it ranks ahead of 75.77% of US stocks.
  • CRON's strongest trending metric is Quality; it's been moving down over the last 179 days.
  • CRON's current lowest rank is in the Momentum metric (where it is better than 0.32% of US stocks).

CRON Stock Summary

  • The ratio of debt to operating expenses for CRONOS GROUP INC is higher than it is for about only 4.89% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.04 for CRONOS GROUP INC; that's greater than it is for merely 6.06% of US stocks.
  • With a year-over-year growth in debt of -81.56%, CRONOS GROUP INC's debt growth rate surpasses just 2.19% of about US stocks.
  • Stocks that are quantitatively similar to CRON, based on their financial statements, market capitalization, and price volatility, are AYTU, PTPI, IDEX, SD, and MXC.
  • Visit CRON's SEC page to see the company's official filings. To visit the company's web site, go to www.thecronosgroup.com.

CRON Valuation Summary

  • CRON's price/sales ratio is 12.5; this is 160.42% higher than that of the median Healthcare stock.
  • CRON's price/sales ratio has moved down 2659.1 over the prior 58 months.

Below are key valuation metrics over time for CRON.

Stock Date P/S P/B P/E EV/EBIT
CRON 2022-11-25 12.5 1.0 -5.3 -2.3
CRON 2022-11-23 12.3 1.0 -5.2 -2.2
CRON 2022-11-22 12.1 1.0 -5.1 -2.2
CRON 2022-11-21 12.4 1.0 -5.2 -2.3
CRON 2022-11-18 12.5 1.0 -5.3 -2.3
CRON 2022-11-17 11.8 0.9 -5.0 -2.0

CRON's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CRON has a Quality Grade of F, ranking ahead of 0.86% of graded US stocks.
  • CRON's asset turnover comes in at 0.03 -- ranking 353rd of 682 Pharmaceutical Products stocks.
  • 500 - Internal server error

The table below shows CRON's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.030 -0.621 -0.378
2021-03-31 0.027 -0.439 -0.870
2020-12-31 0.024 -0.553 -0.242
2020-09-30 0.019 -0.749 0.191
2020-06-30 0.015 -1.350 2.033
2020-03-31 0.014 -1.185 6.271

CRON Price Target

For more insight on analysts targets of CRON, see our CRON price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.63 Average Broker Recommendation 2.42 (Moderate Sell)

CRON Stock Price Chart Interactive Chart >

Price chart for CRON

CRON Price/Volume Stats

Current price $3.46 52-week high $4.73
Prev. close $3.26 52-week low $2.57
Day low $3.15 Volume 3,267,000
Day high $3.51 Avg. volume 2,085,400
50-day MA $2.99 Dividend yield N/A
200-day MA $3.14 Market Cap 1.31B

Cronos Group Inc. - Common Share (CRON) Company Bio


Cronos Group seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marihuana for Medical Purposes Regulations. The firm typically invests in companies based in Canada. Cronos Group was founded in January, 2013 and is based in Toronto, Canada.


CRON Latest News Stream


Event/Time News Detail
Loading, please wait...

CRON Latest Social Stream


Loading social stream, please wait...

View Full CRON Social Stream

Latest CRON News From Around the Web

Below are the latest news stories about CRONOS GROUP INC that investors may wish to consider to help them evaluate CRON as an investment opportunity.

Cronos Group Inc. to Speak at Stifel Canada’s 3rd Annual Future of Healthcare Conference

TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and Chief Executive Officer, will speak at Stifel Canada’s 3rd Annual Future of Healthcare Conference on Wednesday, December 7, 2022 at 1:00 p.m. ET. A webcast will be available on the Investors section of the Company’s website at: https://ir.thecronosgroup.com/events-presentations.

Yahoo | November 29, 2022

Investing in Cronos Australia (ASX:CAU) a year ago would have delivered you a 202% gain

The Cronos Australia Limited ( ASX:CAU ) share price is down a rather concerning 37% in the last month. On the other...

Yahoo | November 23, 2022

Here's Why I'm Closing My Crypto.Com Account in 2023

In the case of Crypto.com that reason used to exist in the form of rewards on my staked funds and other benefits such as crypto rewards on my Crypto.com Card spending. The trouble is that the costs involved are now greater than the rewards I receive. In fact, many traditional credit cards offer better rewards.

Yahoo | November 22, 2022

The Canadian Cannabis Report - Monday, Nov. 21

The past, present and future of the Canadian cannabis sector, based on the performance of the MCCCI, which is a proprietary index of 22 stocks.

TalkMarkets.com | November 21, 2022

7 Growth Stocks With Room to Run in 2023

These are the best growth stocks to buy for 2023 with the business that they represent having potential catalysts.

Faisal Humayun on InvestorPlace | November 18, 2022

Read More 'CRON' Stories Here

CRON Price Returns

1-mo 12.34%
3-mo N/A
6-mo 14.19%
1-year -16.83%
3-year -47.97%
5-year 5.32%
YTD -11.73%
2021 -43.52%
2020 -9.52%
2019 -26.18%
2018 34.43%
2017 600.87%

Continue Researching CRON

Here are a few links from around the web to help you further your research on Cronos Group Inc's stock as an investment opportunity:

Cronos Group Inc (CRON) Stock Price | Nasdaq
Cronos Group Inc (CRON) Stock Quote, History and News - Yahoo Finance
Cronos Group Inc (CRON) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8715 seconds.